Finding key impurities in different manufacturing routes of a drug substance using liquid chromatography/mass spectrometry followed by principal components analysis

被引：4

作者：

Carrier, Dan

Eckers, Christine

Arnoult, Tiffanie

Thurston, Thomas

Major, Hilary

机构：

[1] GlaxoSmithKline Inc, Stevenage SG1 2NY, Herts, England

[2] GlaxoSmithKline Inc, Tonbridge TN11 9AN, England

[3] Waters, Manchester M22 5PP, Lancs, England

来源：

RAPID COMMUNICATIONS IN MASS SPECTROMETRY | 2007年 / 21卷 / 23期

关键词：

D O I：

10.1002/rcm.3284

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：3946 / 3948

页数：3

共 4 条

[1] Development and application of a new on-line SPE system combined with LC-MS/MS detection for high throughput direct analysis of pharmaceutical compounds in plasma [J].

Alnouti, Y ;

Srinivasan, K ;

Waddell, D ;

Bi, HG ;

Kavetskaia, O ;

Gusev, AI .

JOURNAL OF CHROMATOGRAPHY A, 2005, 1080 (02) :99-106

[2] Using chemometrics for navigating in the large data sets of genomics, proteomics, and metabonomics (gpm) [J].

Eriksson, L ;

Antti, H ;

Gottfries, J ;

Holmes, E ;

Johansson, E ;

Lindgren, F ;

Long, I ;

Lundstedt, T ;

Trygg, J ;

Wold, S .

ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2004, 380 (03) :419-429

[3]

MILLER JC, 1993, STAT ANAL CHEM, P57

[4] Chemometrics in metabonomics [J].

Trygg, Johan ;

Holmes, Elaine ;

Lundstedt, Torbjorn .

JOURNAL OF PROTEOME RESEARCH, 2007, 6 (02) :469-479

← 1 →